Literature DB >> 7954403

Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients.

D Ryberg1, A Hewer, D H Phillips, A Haugen.   

Abstract

The levels of aromatic/hydrophobic DNA adducts were analyzed in normal lung tissue from 63 lung cancer patients and examined in relation to exposure and genetic factors. Adduct levels were significantly higher in smokers than in nonsmokers, but among smokers the number of cigarettes smoked per day had only low significance for the variation in adduct levels. An inverse correlation was found between years of smoking and DNA adduct levels (r = 0.52, P = 0.001). Thus, patients with high adduct levels generally had shorter duration of smoking and/or lower smoking dose before the clinical onset of the disease, which fits expected behavior of cancer susceptible individuals. The data indicated an excess of individuals with glutathione S-transferase M1 deficiency among male patients with high adduct levels. Among females the DNA adduct levels were higher than in males when adjusted for smoking dose. There was a highly significant difference in the distribution of males and females when smokers were divided into quartile groups according to adducts per pack year (trend test: 2-sided P = 0.005). This may indicate that women are at greater risk of tobacco-induced lung cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954403

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  The association between methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk.

Authors:  Sulhattin Arslan; Sule Karadayi; Malik Ejder Yildirim; Ozturk Ozdemir; Ibrahim Akkurt
Journal:  Mol Biol Rep       Date:  2010-06-08       Impact factor: 2.316

Review 2.  Lung cancer in women.

Authors:  Angela M Coscio; Jennifer Garst
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

Review 3.  Do you know the sex of your cells?

Authors:  Kalpit Shah; Charles E McCormack; Neil A Bradbury
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

4.  Exposure to urban and rural air pollution: DNA and protein adducts and effect of glutathione-S-transferase genotype on adduct levels.

Authors:  P S Nielsen; H Okkels; T Sigsgaard; S Kyrtopoulos; H Autrup
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

Review 5.  Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis.

Authors:  S Wasswa-Kintu; W Q Gan; S F P Man; P D Pare; D D Sin
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

6.  Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab.

Authors:  H A Wakelee; S E Dahlberg; J R Brahmer; J H Schiller; M C Perry; C J Langer; A B Sandler; C P Belani; D H Johnson
Journal:  Lung Cancer       Date:  2012-01-21       Impact factor: 5.705

Review 7.  Does smoking influence the physical activity and lung cancer relation? A systematic review and meta-analysis.

Authors:  Daniela Schmid; Cristian Ricci; Gundula Behrens; Michael F Leitzmann
Journal:  Eur J Epidemiol       Date:  2016-08-08       Impact factor: 8.082

Review 8.  Lung cancer: epidemiology, etiology, and prevention.

Authors:  Charles S Dela Cruz; Lynn T Tanoue; Richard A Matthay
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

9.  Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women.

Authors:  Michele L Cote; Wonsuk Yoo; Angela S Wenzlaff; Geoffrey M Prysak; Susan K Santer; Gina B Claeys; Alison L Van Dyke; Susan J Land; Ann G Schwartz
Journal:  Carcinogenesis       Date:  2009-01-27       Impact factor: 4.944

10.  Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed?

Authors:  O Ayeni; A Robinson
Journal:  Curr Oncol       Date:  2009-05       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.